herenciageneticayenfermedad: Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States - PubMed

viernes, 6 de noviembre de 2020

Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States - PubMed

Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States - PubMed

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)